Effective 1 de octubre de 2021, the policy for Surgical Treatments for Breast Cancer-Related Lymphedema is being updated to require preauthorization for Medicare Advantage plans and commercial products for the following specific treatments: Lymph node transplant, Lymphovenous bypass, and debulking of a limb. Please click here for coding and additional details.